Fighting against hematological malignancy in China: from unique system to global impact

Abstract

During recent decades, substantial progress has been made in clinical strategies for treating hematological malignancies. Not only did China benefit from the global progression in the management of acute promyelocytic leukemia, risk-stratification-directed strategies for acute or chronic leukemia and haploidentical hematopoietic stem cell transplantation, the unique system developed by Chinese doctors has also become inspiration for refining global clinical practice. The multicenter trials and collaborations adhering to international standards might further strengthen the global impact and lead the way in specific fields of research worldwide.

Keywords: acute myeloid leukemia; acute promyelocytic leukemia; chronic myeloid leukemia; haploidentical hematopoietic stem cell transplantation; hematological malignancy.